symbol,statement_type,period_end,line_item,value
NURECA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-234060000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-1960000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,20840000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,
NURECA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-43230000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,32410000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,140620000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,-80000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-108130000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-1690000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-9860000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,
NURECA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,18880000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,6430000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
NURECA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,6430000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,12450000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-1960000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,14410000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,84390000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
NURECA.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,76200000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,51130000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,1363050000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-1311920000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,
NURECA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,
NURECA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-42940000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,290000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-43230000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,-190830000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-13760000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-104640000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,7450000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-21110000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,14450000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-90670000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-17070000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-64080000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,750000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,23380000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
NURECA.NS,cashflow,2025-03-31 00:00:00,Depreciation,23380000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-45600000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-590000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-220000.0
NURECA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,13430000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-37980000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-290000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,4300000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,
NURECA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-10860000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,140620000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,5040000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,-30000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,135610000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-13030000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-4820000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,
NURECA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,4010000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-290000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,-290000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,0.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,4300000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,0.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,4300000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,175760000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,10000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,96940000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,89670000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,2105190000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-2015520000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,
NURECA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,
NURECA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-10860000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-10860000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,-27120000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,12490000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,53430000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,810000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-13450000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,1850000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,36260000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,27050000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-33650000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,100000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,23620000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,
NURECA.NS,cashflow,2024-03-31 00:00:00,Depreciation,23620000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-58680000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-10000.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
NURECA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,-25440000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,98310000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,60000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,
NURECA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-3960000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,5040000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,82490000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,-90000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-77360000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-15070000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-11870000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,
NURECA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,60000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,60000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,
NURECA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,60000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-164560000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
NURECA.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,12230000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-172830000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,251980000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-424810000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,0.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-3960000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,
NURECA.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-3960000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,102270000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-41470000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,285940000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-18800000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,26140000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,1770000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,287000000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-13760000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-37690000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,3500000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,23880000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,
NURECA.NS,cashflow,2023-03-31 00:00:00,Depreciation,23880000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-24440000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-30000.0
NURECA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,
NURECA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,-107420000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-46000000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-7790000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,
NURECA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,0.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-59990000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,82490000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,172420000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,-10000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-89920000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-73020000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-4340000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-49930000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,0.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,0.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-9220000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-1430000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,
NURECA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-7790000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-7790000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,
NURECA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-30890000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
NURECA.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,40410000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-11310000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,343900000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-355210000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-25950000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-25950000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-34040000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,
NURECA.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-34040000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,13990000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-179510000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-378980000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-9040000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-42710000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,-39590000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-264010000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-26140000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-44990000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,0.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,14820000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,820000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Depreciation,14820000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-6510000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-650000.0
NURECA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,
NURECA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,609810000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
NURECA.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
NURECA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,47360000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,1050000000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
NURECA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
NURECA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
NURECA.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
NURECA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
NURECA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
NURECA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
NURECA.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,1050000000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,1050000000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
NURECA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,
NURECA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
NURECA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
NURECA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,47360000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
NURECA.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
NURECA.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
NURECA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,-3020000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,-3020000.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
NURECA.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
NURECA.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
NURECA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
NURECA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
NURECA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
NURECA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
NURECA.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
NURECA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
NURECA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,0.0
NURECA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
NURECA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
NURECA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
NURECA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
